Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients
Hepsin is a type II transmembrane serine protease whose deregulation promotes tumor invasion by proteolysis of the pericellular components. In colorectal cancer, the implication of hepsin is unknown. Consequently, we aimed to study the correlations between hepsin expression and different clinical-hi...
Main Authors: | David Zaragoza-Huesca, Andrés Nieto-Olivares, Francisco García-Molina, Guillermo Ricote, Sofía Montenegro, Manuel Sánchez-Cánovas, Pedro Garrido-Rodríguez, Julia Peñas-Martínez, Vicente Vicente, Francisco Martínez, María Luisa Lozano, Alberto Carmona-Bayonas, Irene Martínez-Martínez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/13/3106 |
Similar Items
-
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells
by: Maria Carmen Rodenas, et al.
Published: (2023-05-01) -
Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin
by: David Zaragoza-Huesca, et al.
Published: (2023-12-01) -
Hepsin immunohistochemical expression in prostate cancer in relation to Gleason′s grade and serum prostate specific antigen
by: Madhu Mati Goel, et al.
Published: (2011-01-01) -
Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer
by: Lucy Lu, et al.
Published: (2022-01-01) -
Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells
by: Julia Peñas-Martínez, et al.
Published: (2021-05-01)